Drug repurposing approaches to fight Dengue virus infection and related diseases

被引：44
|
作者：
Botta, Lorenzo [1 ]
Rivara, Mirko [2 ]
Zuliani, Valentina [2 ]
Radi, Marco [2 ]
机构：
[1] Univ Tuscia, Biol & Ecol Dept DEB, I-01100 Viterbo, Italy
[2] Univ Parma, Dept Food & Drug, Viale Sci 27-A, I-43124 Parma, Italy
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2018年 / 23卷
关键词：
Dengue virus; Neglected Diseases; Drug repurposing; Review; POTENT INHIBITOR; MYCOPHENOLIC-ACID; HELICASE ACTIVITY; REPLICATION; PROTEIN; CELGOSIVIR; IVERMECTIN; NELFINAVIR; DISCOVERY; FEVER;
D O I：
10.2741/4630
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Dengue is a mosquito-borne viral disease caused by four antigenically distinct serotypes of Dengue Virus (DENV), namely DENV1-4 and is currently considered the most important arthropod-born viral disease in the world. An effective antiviral therapy to treat Dengue Virus infection is still missing and a number of replicative cycle inhibitors are currently under study. Considering the rapid spreading of DENV and the common timeframe required for bringing a new drug on the market, the repurposing of approved drugs used for different diseases to identify novel inhibitors of this pathogen represents an attractive approach for a rapid therapeutic intervention. Herein, we will describe the most recent drug repurposing approaches to fight DENV infection and their implications in antiviral drug-discovery.
引用
收藏
页码：997 / 1019
页数：23
相关论文
共 50 条
  • [41] Drug Repurposing for Rare Diseases: A Role for Academia
    van den Berg, Sibren
    de Visser, Saco
    Leufkens, Hubert G. M.
    Hollak, Carla E. M.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms
    Kato, Fumihiro
    Hishiki, Takayuki
    VIRUSES-BASEL, 2016, 8 (05):
  • [43] Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
    Pinzi, Luca
    Tinivella, Annachiara
    Caporuscio, Fabiana
    Rastelli, Giulio
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Targeting Glucosylceramide Synthase: Innovative Drug Repurposing Strategies for Lysosomal Diseases
    Canini, Giorgia
    Mazzinelli, Elena
    Nocca, Giuseppina
    Lattanzi, Wanda
    Arcovito, Alessandro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [45] Molecular Aspects of the Dengue Virus Infection Process: A Review
    Zonetti, Luiz F. C.
    Coutinho, Milena C.
    de Araujo, Alexandre S.
    PROTEIN AND PEPTIDE LETTERS, 2018, 25 (08) : 712 - 719
  • [46] Molecular pathogenesis of dengue virus infection in Aedes mosquitoes
    Abduljalil, Jameel M.
    Abd Al Galil, Fahd M.
    JOURNAL OF INSECT PHYSIOLOGY, 2022, 138
  • [47] Inhibition of dengue virus infection by mannoside glycolipid conjugates
    Schaeffer, Evelyne
    Flacher, Vincent
    Neuberg, Patrick
    Hoste, Astrid
    Brulefert, Adrien
    Fauny, Jean-Daniel
    Wagner, Alain
    Mueller, Christopher G.
    ANTIVIRAL RESEARCH, 2018, 154 : 116 - 123
  • [48] Nutritional status impacts dengue virus infection in mice
    Chuong, Christina
    Bates, Tyler A.
    Akter, Shamima
    Werre, Stephen R.
    LeRoith, Tanya
    Weger-Lucarelli, James
    BMC BIOLOGY, 2020, 18 (01)
  • [49] Requirement of cholesterol in the viral envelope for dengue virus infection
    Carro, Ana C.
    Damonte, Elsa B.
    VIRUS RESEARCH, 2013, 174 (1-2) : 78 - 87
  • [50] The seroprevalence and seroincidence of dengue virus infection in western Kenya
    Blaylock, Jason M.
    Maranich, Ashley
    Bauer, Kristen
    Nyakoe, Nancy
    Waitumbi, John
    Martinez, Luis J.
    Lynch, Julia
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2011, 9 (05) : 246 - 248
12345